Maura Norden is a seasoned FDA regulatory advisor who has counseled clients for nearly 20 years on regulation, policy, and compliance throughout the product lifecycle. Her expertise spans a wide range of product types—prescription and over-the-counter (OTC) drugs, medical devices (including in vitro diagnostics), laboratory developed tests, digital health products, dietary supplements, and cosmetics—as well as product labeling and promotion.
Most recently, Ms. Norden served as General Counsel and Executive Vice President at Greenleaf Health (now part of ELIQUENT Life Sciences). Combining detail with strategy, her guidance helped clients interpret and comply with evolving regulatory frameworks and requirements. She also provided due diligence services for life sciences investors and co-managed the litigation support group, in addition to leading the firm’s internal legal operations.
Ms. Norden previously practiced law with the food, drug, and medical device regulatory group at the law firm of Sidley Austin LLP. She holds a J.D. from George Washington University Law School and a B.A. from the University of Virginia, where she was a Jefferson Scholar.